Cassava Sciences- Warrants (15/11/2024)'s total assets is $100M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest total assets for SAVAW is $100M as of June 2026. That compares with $140M in the prior-year period — down 23.3% year over year. Investors often review this figure alongside Cassava Sciences- Warrants (15/11/2024)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, SAVAW's total assets moved from $140M to $100M — a 23.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cassava Sciences- Warrants (15/11/2024)'s operating scale or balance-sheet position.
A total assets figure of $100M for SAVAW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting SAVAW's total assets ($100M), review year-over-year change from $140M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Cassava Sciences- Warrants (15/11/2024)'s total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.